Platinib Drug Overview and Specific Use Guidelines

Platinib (trade name: Pujihua) is a cutting-edge targeted therapy drug specially designed for cancer patients with RET gene fusion or mutation, such as non-small cell lung cancer. By precisely targeting the RET protein, it effectively curbs the proliferation and spread of cancer cells, lighting up a new therapeutic dawn for patients.

1. Overview of Drugs

Platinib is a selectiveRET inhibitor, and its unique mechanism of action makes it stand out in the treatment of RET-related cancers. The drug inhibits the growth and survival of cancer cells by blocking the RET signaling pathway, thereby achieving therapeutic goals. The advent of platinib provides a novel and efficient treatment option for patients with RET gene mutations.

2. Standard usage guide

1. Recommended dosage: The recommended dosage of Platinib is 400 mg per day, taken once. Patients should strictly follow the doctor's instructions and do not change the dosage on their own.

2. How to take: Platinib should be taken orally on an empty stomach, that is, an empty stomach should be maintained for at least 2 hours and 1 hour before and after taking the drug. This helps the medication to be fully absorbed and work best.

3. Continuous treatment: Patients should continue to take platinib until their condition worsens or intolerable toxic reactions occur. During treatment, patients should have regular follow-up visits so that doctors can evaluate the efficacy and adjust the treatment plan.

4. Side effect management: If patients experience side effects after taking platinib, such as high blood pressure, liver damage, etc., they should inform their doctor immediately. The doctor may adjust the dosage, temporarily stop the medication, or permanently discontinue the medication based on the patient's specific condition.

5. Special notes:

1) If a patient vomits after taking one dose of Platinib, do not take additional doses and should continue taking the next dose at the normal time the next day.

2)The patient's blood pressure and liver function need to be monitored regularly. In particular, before starting platinib, physicians should assess the patient's liver function (especially ALT and AST enzymes) and monitor it every 2 weeks for the first 3 months and monthly thereafter.

3) If the patient requires surgery, be sure to inform the surgeon that you are currently using platinib, as the drug may need to be temporarily stopped before surgery.

To sum up, Platinib is effective forEffective treatment for cancers with RET gene mutations. Patients should strictly follow the doctor's instructions during use, correctly grasp the dosage and usage, and pay attention to monitoring relevant indicators and side effects. Through scientific and standardized treatment, patients can more effectively control their condition and improve their quality of life.